Glenmark Pharmaceuticals Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,42,384 shares,. Its Average Traded Price (ATP) is ₹2623.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹2619.40.
Glenmark Pharmaceuticals has an upper circuit limit of ₹2869.30 and a lower circuit limit of ₹2347.70. The total value traded stands at ₹37.35 CR, and the delivery percentage for the day is 48.93%.
The stock is currently traded with a market lot size of 1. Glenmark Pharmaceuticals also offers a dividend yield of 0.09%.
Glenmark Pharmaceuticals Share Price Chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
1.42 L
Market Cap
73618.31 CR
LTQ@LTP
3@2619.40
ATP
2623.1
Var Margin
15.25 %
Circuit Range
2347.7-2869.3
Delivery %
48.93 %
Value
37.35 CR
ASM/GSM
No
Market Lot
1
Glenmark Pharmaceuticals Resistance and Support
Pivot 2627.9
Resistance
First Resistance
2647.3
Second Resistance
2686.1
Third Resistance
2705.5
Support
First Support
2589.1
Second Support
2569.7
Third Support
2530.9
Glenmark Pharmaceuticals Futures & Options
2619.4
10.9 (0.42%)
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
23NOV26
0.00
NaN (%)
29DEC26
0.00
NaN (%)
25JAN27
0.00
NaN (%)
GLENMARK|23NOV26 CE 2600.00
23.45
-9.1 (-27.96%)
GLENMARK|23NOV26 PE 2620.00
23.45
-0.9 (-3.7%)
Glenmark Pharmaceuticals Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2024-25
- 2025-26
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-31 | 2026-08-31 | View More |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark reported Q2 FY27 cons. revenue of Rs. 4,247.3 crores, reflecting a 20% YoY like-for-like growth. Adjusted net profit stood at Rs. 485.2 crores, while EBITDA margin was 20.3% driven by strong core performance across regions.
Nov 05 2026 17:17:57
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark's IGI will present updated Phase 1 clinical data for its investigational multiple myeloma treatment, ISB 2001, at the 68th ASH Annual Meeting. The data demonstrates robust efficacy and tolerability in heavily pretreated patients, with the oral presentation scheduled for 12 Dec 2026.
Nov 04 2026 19:42:28
Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of Glenmark Pharmaceuticals Limited ('The Company') For The Quarter And Half Year Ended September 30, 2026
Glenmark Pharmaceuticals board to meet on November 5, 2026 for financial results. The meeting will cover performance for the quarter and half year ended September 30, 2026.
Oct 23 2026 11:44:11
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Mankind Pharma Ltd.
2638.00
9.00 (0.34%)
Aurobindo Pharma Ltd.
1805.40
-0.30 (0.02%)
Max Healthcare Institute Ltd.
1077.00
36.35 (3.49%)
Manipal Health Enterprises Ltd.
710.10
13.65 (1.96%)
Lupin Ltd.
1990.10
-8.70 (0.44%)
Aster DM Quality Care Ltd.
762.70
23.40 (3.17%)
Alkem Laboratories Ltd.
5155.00
10.00 (0.19%)
Fortis Healthcare Ltd.
818.80
8.95 (1.11%)
Biocon Ltd.
362.10
-1.55 (0.43%)
Abbott India Ltd.
26095.00
400.00 (1.56%)
Glenmark Pharmaceuticals FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLENMARK
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC